STOCK TITAN

Utah Med Prods SEC Filings

UTMD NASDAQ

Welcome to our dedicated page for Utah Med Prods SEC filings (Ticker: UTMD), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

Utah Medical Products Inc. filings document formal disclosures for a Utah-incorporated medical device manufacturer whose common stock trades on Nasdaq under the symbol UTMD. Recent Form 8-K reports furnish quarterly and annual financial information, including sales, margins, earnings measures and exhibits containing the company's financial-performance releases.

The filing record also covers governance and capital-return matters. Definitive proxy materials describe director elections, auditor ratification, advisory executive-compensation votes and annual meeting procedures, while 8-K reports record stockholder voting results, board appointments, committee service, director compensation arrangements and quarterly dividend announcements.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other

FAQ

How many Utah Med Prods (UTMD) SEC filings are available on StockTitan?

StockTitan tracks 23 SEC filings for Utah Med Prods (UTMD), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.

When was the most recent SEC filing for Utah Med Prods (UTMD)?

The most recent SEC filing for Utah Med Prods (UTMD) was filed on July 15, 2025.